Fairman Group
MRK icon

Fairman Group’s Merck MRK Stock Holding History

Fairman Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$87.8K Sell
601
-68
-10% -$9.4K 0.06% 81
2026
Q2 		$86.6K Sell
669
-121
-15% -$14.2K 0.07% 81
2026
Q1 		$95.7K Hold
790
– – 0.08% 74
2025
Q4 		$83.8K Hold
790
– – 0.07% 79
2025
Q3 		$66.9K Hold
790
– – 0.05% 91
2025
Q2 		$63.2K Sell
790
-123
-13% -$9.8K 0.05% 93
2025
Q1 		$93.3K Sell
913
-518
-36% -$48.4K 0.09% 78
2024
Q4 		$143K Sell
1,431
-18
-1% -$1.86K 0.12% 68
2024
Q3 		$166K Hold
1,449
– – 0.15% 64
2024
Q2 		$180K Hold
1,449
– – 0.18% 59
2024
Q1 		$192K Sell
1,449
-640
-31% -$78.9K 0.18% 52
2023
Q4 		$229K Buy
+2,089
New +$217K 0.22% 44

Other funds holding MRK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Fairman Group's MRK Position: Q3 2026 in Review

Fairman Group reduced its Merck (MRK) stake by 10% in Q3 2026, selling an estimated $9.4K and leaving 601 shares worth $87.8K. The position accounts for 0.06% of the portfolio, ranked #81.

Fairman Group first reported a position in MRK in Q4 2023 and has held it in 12 quarters since. The position peaked at $229K in Q4 2023. 2,192 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Fairman Group held 601 shares of Merck worth $87.8K as of Q3 2026.
  • Fairman Group sold 68 Merck shares in Q3 2026, an estimated $9.4K.
  • Merck made up 0.06% of Fairman Group's portfolio in Q3 2026, its #81 holding.
  • Fairman Group first reported a position in Merck in Q4 2023 and has held it in 12 quarters since.
  • Fairman Group's Merck position peaked at $229K in Q4 2023.
  • 2,192 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Fairman Group's 13F filing for Q3 2026, filed 26 Oct 2026.